Epidemiology of lymphomas

Current Opinion in Oncology

Volumn 12, Issue 5, 2000, Pages 383-394

  Baris, Dalsu ^a   Zahm, Shelia Hoar ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HAIR DYE; PESTICIDE; SOLVENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CANCER EPIDEMIOLOGY; CLINICAL RESEARCH; DIAGNOSTIC ERROR; DIET; DISEASE PREDISPOSITION; HODGKIN DISEASE; HUMAN; INCIDENCE; LYMPHOMA; NONHODGKIN LYMPHOMA; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; REVIEW; UNITED STATES; VIRUS;

FEMALE; HUMANS; INCIDENCE; LYMPHOMA; MALE; UNITED STATES; WORLD HEALTH;

EID: 0034457812     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200009000-00002     Document Type: Review

References (171)

1. Cancer statistics, 2000
2. Hodgkin's and non-Hodgkin's lymphomas
3. Quantification of the impact of known risk factors on time trends in non-Hodgkin's lymphoma incidence
4. Another view of the epidemiology of non-Hodgkin's lymphoma
5. Epidemiology of non-Hodgkin's lymphoma: Recent data
6. Time trends in Hodgkin's disease incidence: The role of diagnostic accuracy
7. Hodgkin's disease
8. Overview of the epidemiology of malignancy in immune deficiency
9. Immunodeficiency-associated lymphoproliferative disorders
10. Primary immunodeficiencies: Genetic risk factors for lymphoma
11. Non-Hodgkin's lymphoma in pediatric patients with chromosomal breakage syndromes (AT and NBS): Experience from the BFM trials
12. Common variable immunodeficiency: Clinical and immunological features of 248 patients
13. Relationship of immunodeficiency to lymphoid malignancy
14. The Wiskott-Aldrich syndrome in the United States and Canada (1892-1979)
15. Immunologic factors, including AIDS
16. Collaborative United Kingdom-Australasian study of cancer in patients treated with immunosuppressive drugs
17. Lymphoma risks in populations with altered immunity - A search for mechanism
18. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients
19. Epstein-Barr virus in pediatric patients after renal transplantation
20. Risk of lymphoid neoplasia after cardiothoracic transplantation: A cohort study of the relation to Epstein-Barr virus
21. Risk of lymphoproliferative disorders after bone marrow transplantation: A multi-institutional study
22. Non-Hodgkin's lymphoma
23. Prognostic value of chromosomal abnormalities in follicular lymphoma
24. Genetic polymorphisms in the tumor necrosis factor locus influence non-Hodgkin's lymphoma outcome
25. Non-Hodgkin's lymphoma and family history of malignant tumors in a case-control study (United States)
26. The epidemiology of AIDS-related neoplasms
27. Non-Hodgkin's lymphoma among people with AIDS: Incidence, presentation and public health burden
28. Spectrum of AIDS-associated malignant disorders
29. AIDS-related lymphoma
30. Advances in the epidemiology of HIV-associated non-Hodgkin's lymphoma and other lymphoid neoplasms
31. B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS
32. Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS clinical trial group study participants
33. AIDS-associated non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy
34. Chemokine and chemokine receptor gene variants and risk of non- Hodgkin's lymphoma in human immunodeficiency virus-1-infected individuals
35. Susceptibility genes for AIDS and AIDS-related lymphoma
36. Chemokines and leukocyte traffic
37. Epstein-Barr virus-associated malignancies: Epidemiologic patterns and etiologic implications
38. The epidemiology of HTLV-I infection
39. Human retroviruses: Their role in cancer
40. Human T-lymphotropic virus type I infection
41. Evaluation of adult T-cell leukemia/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan
42. Evidence among blood donors for a 30-year-old epidemic of human T lymphotropic virus type II infection in the United States
43. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders
44. Hepatitis C virus infection among cryoglobulinemic and non-cryoglebulinemic B-cell non-Hodgkin's lymphomas
45. Lack of association between hepatitis C infection and development of AIDS-related lymphoma
46. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
47. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma
48. High prevalence of hepatitis C virus infection in patients with non-Hodgkin's lymphoma at the onset. Preliminary results of an Italian multicenter study
49. Hepatitis C virus infection and lymphoproliferative diseases in France: A national study
50. Hepatitis C virus in non-Hodgkin's lymphoma: A reappraisal after a prospective case-control study of 300 patients
51. Risk of non-Hodgkin's lymphoma in patients with hepatitis C virus infection
52. Hepatitis C virus infection, mixed cryoglobulinemia, and non-Hodgkin's lymphoma: An emerging picture
53. Primary effusion lymphoma cell lines harbouring human herpesvirus type-8
54. Early peripheral lymph node involvement of human herpesvirus 8-associated, body cavity-based lymphoma in a human immunodeficiency virus-negative patient
55. Human herpes virus-8 associated primary effusion lymphoma of the pleural cavity in HIV-negative elderly men
56. The role of Helicobacter pylori in primary gastric MALT lymphoma
57. The effect of Helicobacter pylori on cell proliferation and apoptosis in gastric epithelial cell lines
58. Hematepoietic cancer and peptic ulcer: A multicenter case-control study
59. Helicobacter pylori infection and gastric lymphoma
60. Eradication of Helicobacter pylori and stability of remissions in low-grade gastric B-cell lymphomas of the mucosa-associated lymphoid tissue: Results of an ongoing multicenter trial
61. Increased risk of lymphoid and nonlymphoid malignancies in patients with lymphomatoid papulosis
62. Medical history risk factors for non-Hodgkin's lymphoma in older women
63. Cancer and diabetes - A follow-up study of two population-based cohorts of diabetic patients
64. Transfusion history and cancer risk in older women
65. Lymphomas in patients with Sjogren's syndrome: Review of the literature and physiopathologic hypothesis
66. Rheumatoid arthritis and cancer risk
67. Longterm mortality outcome in patients with rheumatoid arthritis: Early presenters continue to do well
68. Medical history and risk of Hodgkin's and non-Hodgkin's lymphomas
69. Haematopoietic cancer and medical history: A multicentre case control study
70. Case-control study of non-Hodgkin's lymphoma among women and heterosexual men in the San Francisco Bay Area, California
71. Radiation and non-Hodgkin's lymphoma
72. Some risk factors for non-Hodgkin's lymphoma
73. Cancer mortality in health and science technicians
74. Electrical wiring configurations and childhood cancer
75. Case-control study of childhood cancer and exposure to 60hz magnetic fields
76. Increased mortality in amateur radio operators due to lymphatic and hematopoietic malignancies
77. A review of epidemiological studies of the health effects of living near or working with electricity generation and transmission equipment
78. Lymphomas in Ev-PimI transgenic mice exposed to pulsed 900 MHz electromagnetic fields
79. Exposure to 60 Hz magnetic fields and risk of lymphoma in PIM transgenic and TSG-p53 (p53 knockout) mice
80. Non-Hodgkin's lymphoma among electric utility workers in Ontario: The evaluation of alternate indices of exposure to 60 Hz electric and magnetic fields
81. Pesticides and non-Hodgkin's lymphoma
82. Pesticides and cancer
83. Agricultural herbicide use and risk of lymphoma and soft-tissue sarcoma
84. Maligant lymphoma and exposure to chemicals, especially organic solvents, chlorophenols and phenoxy acids: A case-control study
85. Mortality study of Canadian male farm operators: Non-Hodgkin's lymphoma mortality and agricultural practices in Saskatchewan
86. A case-control study of non-Hodgkin's lymphoma and the herbicide 2,4-dichlorophenoxyacetic acid (2,4-D) in eastern Nebraska
87. Exposure to phenoxyacetic acids, chlorophenols, or organic solvents in relation to histopathology, stage, and anatomical localization of non-Hodgkin's lymphoma
88. Pesticides and other agricultural risk factors for non-Hodgkin's lymphoma among men in Iowa and Minnesota
89. Non-Hodgkin's lymphoma and agricultural use of the insecticide lindane
90. Non-Hodgkin's lymphoma and exposure to phenoxyherbicides, chlorophenols, fencing work, and meat works employment: A case-control study
91. Soft tissue sarcoma and non-Hodgkin's lymphoma in relation to phenoxyherbicide and chlorinated phenol exposure in western Washington
92. Can traditional epidemiology detect cancer risks caused by occupational exposure to pesticides?
93. A case-control study of non-Hodgkin lymphoma and exposure to pesticides
94. Occupational exposures, animal exposure and smoking as risk factors for hairy cell leukaemia evaluated in a case-control study
95. Occupational chlorophenol exposure and non-Hodgkin's lymphoma
96. Cancer risk among female agricultural workers: A multi-center case-control study
97. Risk factors for primary central nervous system lymphoma: A case-control study
98. Cancer mortality among women employed in health care occupations in 24 US states, 1984-1993
99. Cancer Mortality among chemists
100. Epidemiologic study of the mortality of British chemists
101. The cancer mortality among Swedish chemists graduated during 3 decades: A comparison with the general population and with a cohort of architects
102. Cancer in laboratory workers
103. Mortality study of workers employed by the Italian National Institute of Health, 1960-1989
104. Mortality among laboratory workers employed at the United States Department of Agriculture
105. Cancer mortality among women employed in fastgrowing US occupations
106. Occupational, environmental, and life-style factors associated with the risk of hematolymphopoietic malignancies in women
107. Cancers in concrete workers: Results of a cohort study of 33 668 workers
108. Associations between several sites of cancer and 9 organic dusts: Results from an hypothesis generating case-control study in Montreal, 1979-1983
109. Lymphohaematopoietic malignancy around all industrial complexes that include major oil refineries in Great Britain
110. Tobacco and non-Hodgkin's lymphoma: Combined analysis of three case-control studies (United States)
111. The epidemiology of non-Hodgkin's lymphoma in the northeast of Italy: A hospital-based case-control study
112. Smoking and risk of non-Hodgkin's lymphoma and multiple-myeloma
113. Is cigarette smoking a risk factor for non-Hodgkin's lymphoma or multiple myeloma: Results from the Lutheran brotherhood cohort study
114. Re: "Relation of cigarette smoking to non-Hodgkin's lymphoma among middle-aged men"
115. Relation of cigarette smoking to non-Hodgkin's lymphoma among middle-aged men
116. Use of hair coloring products and the risk of lymphoma, multiple myeloma, and chronic lymphocytic leukemia
117. Hair dye use and risk of leukemia and lymphoma
118. A case-control study of non-Hodgkin's lymphoma
119. Hair dye use and risk of fatal cancers in United States women
120. A prospective study of permanent hair dye use and hematopoietic cancer
121. Hair-color products and risk for non-Hodgkin's lymphoma: A population-based study in the San Francisco Bay area
122. Deaths from hematopoietic and other cancers in relation to permanent hair dye use in a large prospective study (United States)
123. The increasing incidence of non-Hodgkin's lymphoma (NHL): The possible role of sunlight
124. Ultraviolet light and non-Hodgkin's lymphoma
125. Association between incidence of non-Hodgkin's lymphoma and solar ultraviolet radiation in England and Wales
126. Have increases in solar ultravioret exposure contributed to the rise in incidence of non-Hodgkin's lymphoma?
127. Evidence of an association between non-Hodgkin's lymphoma and skin cancer
128. New primary cancers after squamous cell skin cancer
129. Non-Hodgkin's lymphoma and skin malignancies: Shared etiology
130. Non-Hodgkin's lymphomas, chronic lymphocytic leukaemias and skin cancers
131. Non-Hodgkin's lymphoma and sunlight
132. Residential and occupational exposure to sunlight and mortality from non-Hodgkin's lymphoma: Composite (threefold) case-control study
133. Sunlight and non-Hodgkin's lymphoma: A population-based cohort study in Sweden
134. Occupational physical activity and non-Hodgkin's lymphoma
135. Lymphomas and animal-protein consumption
136. Diet and risk of non-Hodgkin's lymphoma in older women
137. Diet and risk of lymphoid neoplasms and soft tissue sarcomas
138. Dietary factors and non-Hodgkin's lymphoma: A case-control study in the northeastern part of Italy
139. Vegetable and fruit consumption and cancer risk
140. Drinking water nitrate and the risk of non-Hodgkin's lymphoma
141. Dietary factors and non-Hodgkin's lymphoma in Nebraska (United States)
142. Dietary fat and protein in relation to risk of non-Hodgkin's lymphoma among women
143. Non-Hodgkin's lymphoma and nitrate in drinking water: A study in Yorkshire, United Kingdom
144. Tobacco, alcohol, diet and risk of non-Hodgkin's lymphoma: A case-control study in Uruguay
145. Alcohol-consumption and risk of leukemia, non-Hodgkins lymphoma, and multiple-myeloma
146. Alcohol, tobacco and recreational drug use and the risk of non-Hodgkin's lymphoma
147. Non-Hodgkin's lymphoma: Case control epidemiological study in Yorkshire
148. Risk factors for non-Hodgkin's lymphomas in acquired immunodeficiency syndrome (AIDS)
149. Smoking habits and non-Hodgkin's lymphoma: A case-control study in northern Italy
150. Alcohol consumption and non-Hodgkin's lymphoma in a cohort of older women
151. Hodgkin's disease
152. Hodgkin's disease
153. The roles of human viruses in the pathogenesis of lymphoma
154. Epstein-Barr virus distribution in Hodgkin's disease in an unselected Swedish population
155. Hodgkin disease in children: Clinicoepidemiologic and viral (Epstein-Barr virus) analyses
156. Epstein-Barr virus and Hodgkin's disease: Further evidence for the three disease hypothesis
157. Epstein-Barr virus and other candidate viruses in the pathogenesis of Hodgkin's disease
158. Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders in Southern Turkey
159. Space-time clustering of Hodgkin's disease in parts of the UK, 1984-1993
160. An assessment of spatial clustering of leukaemias and lymphomas among young people in New Zealand
161. Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation
162. Risk of cancer in patients with HIV disease
163. Aids and cancer in Africa: The evolving epidemic in Zimbabwe
164. Further investigation of the role of HLA-DPB1 in adult Hodgkin's disease (HD) suggests an influence on susceptibility to different HD subtypes
165. Cancer incidence after total knee arthroplasty: A nationwide Finnish cohort from 1980 to 1996 involving 944 patients
166. Hodgkin's disease, work, and the environment: A review
167. Meta-analysis of Hodgkin's disease among farmers